Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 6/20 | 0.55 |
| ▸ | PRKACB | P22694 | 1/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | CCKBR | P32239 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16509098 | 0.93 | GHSR (0.57) | GHSRPRKACBIL23RNPBWR1RXFP1 | |
| SCHEMBL16508980 | 0.90 | IL23R (0.58) | GHSRPRKACBIL23RNPBWR1RXFP1 | |
| SCHEMBL15748394 | 0.89 | IL23R (0.57) | GHSRPRKACBIL23RRXFP1CCKBR | |
| SCHEMBL16508974 | 0.89 | KISS1R (0.61) | GHSRPRKACBIL23RNPBWR1RXFP1 | |
| SCHEMBL16508998 | 0.89 | GHSR (0.61) | GHSRIL23RCCKBR | |
| SCHEMBL31232428 | 0.88 | GHSR (0.52) | GHSRPRKACBIL23RCCKBR | |
| SCHEMBL29483770 | 0.87 | GHSR (0.60) | GHSRPRKACBNPBWR1 | |
| SCHEMBL29641173 | 0.87 | GHSR (0.60) | GHSRPRKACBNPBWR1 | |
| SCHEMBL29483769 | 0.87 | GHSR (0.60) | GHSRPRKACBNPBWR1 | |
| SCHEMBL13881781 | 0.87 | KISS1R (0.50) | GHSRPRKACBIL23RRXFP1CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173084-A1 | PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS | TAVANTA THERAPEUTICS HUNGARY INCORPORATED (HU) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173084-A1 | PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS | CFTR, SLC26A3, SLC26A4 | GHSR 989/4885PRKACB 3094/4885IL23R 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.